MRK - Financial Reports List - Merck & Co., Inc. - IntrinsicAlpha

Merck & Co., Inc. MRK

Healthcare - Drug Manufacturers - General - NYSE - US

$ 78.525

-0.192 %

$ 198 B

Market Cap

11.55

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	6.79%	405.30%	580.62%
Annual Report	FY	10-K	2024-12-31	6.74%	4589.59%	668.18%
Quarterly Report	Q3	8-K	2024-09-30	4.35%	-33.47%	-35.54%
Quarterly Report	Q2	8-K	2024-06-30	7.16%	191.30%	231.22%
Quarterly Report	Q1	8-K	2024-03-31	8.89%	68.81%	61.34%
Quarterly Report	Q4	8-K	2023-12-31	5.78%	-40.64%	-36.65%
Annual Report	FY	10-K	2023-12-31	1.40%	-97.49%	-84.77%
Quarterly Report	Q3	8-K	2023-09-30	6.70%	46.09%	40.86%
Quarterly Report	Q2	8-K	2023-06-30	3.03%	-151.50%	-89.14%
Quarterly Report	Q1	8-K	2023-03-31	-8.89%	-34.55%	-39.53%

1